Medications for Refractory Anemia
3 results
Azacitidine (azacitidine)
(AZACITIDINE)Eugia US LLC
Usage: Azacitidine for injection is indicated for treating adult patients with specific myelodysplastic syndrome subtypes, including refractory anemia, refractory anemia with ringed sideroblasts (with complications), refractory anemia with excess blasts, and chronic myelomonocytic leukemia. Pediatric use is not labeled due to marketing exclusivity.
Azacitidine (azacitidine)
(Azacitidine)Cipla USA Inc.
Usage: Azacitidine for injection is indicated for adult patients with myelodysplastic syndromes (MDS), specifically subtypes such as refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia.
Polivy (polatuzumab vedotin)
(polatuzumab vedotin)Genentech, Inc.
Usage: POLIVY is indicated for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL) in combination with R-CHP, and for those with relapsed or refractory DLBCL after at least two prior therapies when used with bendamustine and rituximab.